Seer Reports 34% Q1 Revenue Drop to $2.8M, Reaffirms Full-Year Guidance
SEER is trading near its 52-week low of $1.65 (3.0% above the low).
Summary
Seer reported a significant 34% year-over-year decline in first-quarter 2026 revenue, reaching $2.8 million, primarily due to a depressed academic funding environment and competitive activity. Despite the revenue drop, the company reaffirmed its full-year 2026 revenue outlook of $16 million to $18 million, implying a substantial recovery in the remaining quarters. Positively, Seer also reported an improved net loss of $16.8 million, down from $19.9 million in the prior year, driven by a 20% reduction in operating expenses. The company ended the quarter with a strong cash position of approximately $220 million and highlighted operational achievements including a new collaboration and successful IP defense, following a recent CCO appointment and patent lawsuit. Traders will weigh the concerning revenue miss against management's confidence in the full-year outlook and the company's cost control efforts and strong cash balance.
At the time of this announcement, SEER was trading at $1.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $99.9M. The 52-week trading range was $1.65 to $2.41. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.